{"name":"MetrioPharm AG","slug":"metriopharm-ag","ticker":"","exchange":"","domain":"","description":"MetrioPharm AG is a biotechnology company focused on the development of novel anti-inflammatory drugs. The company's lead candidate, MP1032, is currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQZG1RclV6RzluMk9xWnZldHdsWUh1VGVZT09CZVBjWG0wUW15akpmbHNxQUZTaG12VjJiUmV1T3ZSbTF3SmVuTTlJell1aEJiRlVfZzNFamdLbUlhRk0yQjZlVVNfWThHYjFsdko5Y0lHWnhzS3d0U2h0WUpfZU5iMlRTVXJ3d1FEYnBsanY4d0s5bVU?oc=5","date":"2025-07-30","type":"regulatory","source":"Pharmaceutical Technology","summary":"MetrioPharm gains orphan drug status from EMA for MP1032 - Pharmaceutical Technology","headline":"MetrioPharm gains orphan drug status from EMA for MP1032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9jNGI2Z3RzY0xQbHRIZjRZakt1THJFVmFaX0M4NzRhX0IzTmk1OExYZjE3Q2Y2bGt1a3ZyRkRCMkJydWNneVdJU2stTUdBM3Z0VTNZU3VJdVNvTDQxVDQxc1ptaXR6a2EwbHU0MjczODltM3NNNjBVUw?oc=5","date":"2022-12-09","type":"trial","source":"Labiotech.eu","summary":"MetrioPharm reveals COVID-19 study data - Labiotech.eu","headline":"MetrioPharm reveals COVID-19 study data","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}